GIP Decreases Valine Consumption in the VAT of Non-Obese Controls, and It Increases Valine and Pyroglutamate Consumption in the VAT of Patients with Obesity and Obesity with Concomitant Prediabetes, Respectively. The gene discussed is GIP; the disease is prediabetes syndrome.